- Home
- RNA vs SMG Comparison
RNA vs SMG Comparison
Compare RNA & SMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | SMG |
|---|---|---|
| Founded | 2012 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNA | SMG |
|---|---|---|
| Price | $71.76 | $53.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 6 |
| Target Price | $69.26 | ★ $69.50 |
| AVG Volume (30 Days) | ★ 2.9M | 751.1K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 4.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.47 |
| Revenue | $20,868,000.00 | ★ $3,413,100,000.00 |
| Revenue This Year | $64.11 | $2.49 |
| Revenue Next Year | $37.25 | $2.06 |
| P/E Ratio | ★ N/A | $21.79 |
| Revenue Growth | ★ 106.27 | N/A |
| 52 Week Low | $21.51 | $45.61 |
| 52 Week High | $71.79 | $79.12 |
Technical Indicators
Market Signals| Indicator | RNA | SMG |
|---|---|---|
| Relative Strength Index (RSI) | 77.56 | 42.54 |
| Support Level | $71.42 | $55.40 |
| Resistance Level | $71.76 | $57.23 |
| Average True Range (ATR) | 0.41 | 1.74 |
| MACD | -0.73 | -0.01 |
| Stochastic Oscillator | 88.32 | 27.98 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About SMG Scotts Miracle-Gro Company (The)
Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The business consists of three reporting segments: US consumer, Hawthorne, and other. The US consumer segment consists of a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Hawthorne sells indoor gardening and hydroponic equipment, particularly to the cannabis growing industry, while the other segment primarily consists of lawn and gardening products sold in Canada. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.